Uncategorized

COVID-19 Research Products

September 4, 2020
Acanthus Research Inc. is proud to support the Coronavirus research with small molecules that have documented activity against Coronaviruses. Check out our products aimed to support the scientific community in the...
Read More

Service Resilience

March 26, 2020
ACANTHUS RESEARCH INC remains open As we address a pandemic that will no doubt become a chapter in the history books, our commitment to you will not waver. Of course,...
Read More

New Products of the Month

October 30, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every...
Read More

Meet with Us @ CVG 2019 Seminar

October 15, 2019
If you are interested in preparation and characterization of pharmaceutical reference standards, join us at CVG* 2019 Evening Seminar hosted by Covar Pharmaceuticals Inc. on Oct. 17. John Tobin, Director...
Read More

New Products

March 21, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every...
Read More

Nilotinib Potentially Genotoxic Impurities

February 2, 2015
Analytical reference standards of three potentially genotoxic impurities of nilotinib (Tasigna) are now available from Acanthus Research: Nilotinib Genotoxic Impurity 1 (CAS No. 641571-11-1), Nilotinib Genotoxic Impurity 2 (CAS No.1157857-29-8), and...
Read More